Jennifer Rodriguez
Special Relations (Host)
Replay available
Nutex Health Inc. (NASDAQ: NUTX) Q1 2025 earnings conference call, held 2025-05-14. Replay captured from the company's public earnings webcast.

Special Relations (Host)
Chief Operating Officer
Analyst, Green Capital
Chief Financial Officer
Analyst
Chairman and Chief Executive Officer
At this time, I'll turn the floor over to your host, Jennifer Rodriguez, Special Relations for NewTex. Jennifer, you may begin. Good morning, everyone, and welcome to New Tech's House, Inc.' 's first quarter 2025 earnings call. I'm Jennifer Rodriguez, and I'm pleased to moderate today's discussion. Thank you for joining us as we review our performance and outline our plans for the future. This call is being recorded for future reference. With me today are our two leaders, Dr. Tom Bowe, Chairman and CEO, John Bates, Chief Financial Officer, Dr. Warren Hossain, President, and Josh Petrillo, Chief Operating Officer. They will provide insights into our financial results, operational progress, and strategic direction, followed by a Q&A session. Before we begin, a few reminders. Today's discussion may include forward-looking statements based on management's current expectations. These are subject to risks and uncertainties that could cause actual results to differ. For details, please refer to our press release and Form 10Q filed yesterday and our other SEC filings. We'll also discuss non-GAAP measures, like adjusted EBITDA, with reconciliations available in our press release and form 10-Q. With that, I'm pleased to turn the call over to Dr. Tom Vo, our founder and CEO. Dr. Vo, the floor is yours. Thank you, Jennifer, and good morning, everyone. I am pleased to present NewTek Health's results for the first quarter of 2025. which reflects continued progress following a strong 2024. Our mission of deliberating accessibility with high-quality care and a patient-first approach has driven consistent growth and operational stability. Operationally, Q1 2025 shows steady progress, with total patient visits reaching 48,269 patients. a 20.5% increase from 40,068 in Q1 2024. Mature h...